Categories: Business

NR Group Honoured with 'Excellence in Multigenerational Legacy' Award at the Family Business Summit & Awards 2025

At the Family Business Summit & Awards 2025, NR Group was honoured with the prestigious Excellence in Multigenerational Legacy award, recognising its enduring values and visionary leadership across generations.
 

- Advertisement -

NR Group, a diversified business conglomerate headquartered in Mysuru, has evolved over its 77-year legacy from humble beginnings in 1948 as an incense stick (agarbathi) manufacturer into a global powerhouse with a strong presence across sectors including FMCG, aerospace, and defense.
 

- Advertisement -

Mr. Pavan Ranga, CEO of Rangsons Aerospace, receives the ‘Excellence in Multigenerational Legacy’ award, celebrating 77 years of the Ranga Rao family’s legacy
 

- Advertisement -

Mr. Pavan Ranga, CEO & MD of Rangsons Aerospace, accepted the award on behalf of NR Group—an organisation renowned for its legacy of innovation, purposeful leadership, and sustained growth over the decades.
 

- Advertisement -

Built on strong family values and a deep commitment to nation-building, the Group continues to grow while remaining true to its founding principles.
 

- Advertisement -

About Rangsons Aerospace
Rangsons is a diversified business conglomerate based in Mysuru, India, and a part of the NR Group, which was founded in 1948. The group operates across multiple sectors, including Defence and Aerospace, Education, Infrastructure, Agriculture, and Healthcare. Rangsons serves a wide range of clients, both domestically and internationally, collaborating with prestigious organizations such as ISRO, Boeing, and various branches of the Indian Defence and Aerospace sector. The group is dedicated to leveraging technology to develop innovative solutions that address the critical challenges of a developing economy. Its flagship company, N. Ranga Rao & Sons, is a dominant player in the Indian incense industry, best known for its iconic brand, Cycle Pure Agarbathi.

- Advertisement -
News Voir

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

7 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

2 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

3 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

3 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago